Free Trial

vTv Therapeutics (VTVT) Institutional Ownership

vTv Therapeutics logo
$31.04 -0.64 (-2.02%)
Closing price 04:00 PM Eastern
Extended Trading
$31.16 +0.12 (+0.37%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for vTv Therapeutics (NASDAQ:VTVT)

Current
Institutional Ownership
Percentage
17.51%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$2.83M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$49.41K
Get VTVT Insider Trade Alerts

Want to know when executives and insiders are buying or selling vTv Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

VTVT Institutional Buying and Selling by Quarter

vTv Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026683 Capital Management LLC18,268$731K0.0%N/A0.464%
2/10/2026Goldman Sachs Group Inc.5,531$221K0.0%N/A0.140%
2/9/2026Geode Capital Management LLC28,194$1.13M0.0%+84.3%0.716%
11/17/2025Millennium Management LLC12,935$301K0.0%-14.0%0.328%
11/17/2025Baker BROS. Advisors LP148,314$3.46M0.0%+52.4%3.766%
5/14/2025Connective Capital Management LLC9,377$162K0.1%N/A0.294%
2/12/2025Geode Capital Management LLC11,634$158K0.0%+12.9%0.365%
2/12/2025JPMorgan Chase & Co.1,803$25K0.0%N/A0.057%
11/13/2024FMR LLC178,200$2.40M0.0%N/A5.920%
5/15/2024Baker BROS. Advisors LP97,314$2.29M0.0%N/A3.233%
11/8/2023Pathstone Family Office LLC242,937$116K0.0%N/A0.232%
2/9/2023HBK Sorce Advisory LLC57,694$38K0.0%N/A0.055%
8/8/2022Simon Quick Advisors LLC30,000$36K0.0%N/A0.033%
2/15/2022Samsara BioCapital LLC1,635,509$1.63M0.3%N/A1.816%
2/10/2022Rafferty Asset Management LLC69,067$69K0.0%+26.7%0.077%


VTVT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VTVT shares?

During the previous two years, the following institutional investors and hedge funds held shares of vTv Therapeutics shares: Baker BROS. Advisors LP ($3.46M), FMR LLC ($2.40M), Geode Capital Management LLC ($1.13M), 683 Capital Management LLC ($731K), Millennium Management LLC ($301K), Goldman Sachs Group Inc. ($221K), and Connective Capital Management LLC ($162K).Learn more on vTv Therapeutics' institutional investors.

What percentage of vTv Therapeutics' stock is owned by institutional investors?

17.51% of vTv Therapeutics' stock is owned by institutional investors. Learn more on VTVT's institutional investor holdings.

Which institutional investors have been buying vTv Therapeutics' stock?

The following institutional investors have purchased vTv Therapeutics' stock in the last 24 months: FMR LLC ($178.20K), Baker BROS. Advisors LP ($148.31K), 683 Capital Management LLC ($18.27K), Geode Capital Management LLC ($14.22K), Connective Capital Management LLC ($9.38K), Goldman Sachs Group Inc. ($5.53K), and JPMorgan Chase & Co. ($1.80K).

How much institutional buying is happening at vTv Therapeutics?

Institutional investors have bought a total of 97,072 shares in the last 24 months. This purchase volume represents approximately $2.83M in transactions.

Which of vTv Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold vTv Therapeutics stock in the last 24 months: Millennium Management LLC ($2.11K).

How much institutional selling is happening at vTv Therapeutics?

Institutional investors have sold a total of 2,107 shares in the last 24 months. This volume of shares sold represents approximately $49.41K in transactions.



This page (NASDAQ:VTVT) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners